Stifel Financial’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Stifel Financial’s Portfolio BBC Stock Details BBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,081	Closed	-$204K	–	3336
2021 Q2	$204K	Sell	4,081 -205	-5%	-$10K	﹤0.01%	3126
2021 Q1	$220K	Buy	4,286 +45	+1%	+$2.46K	﹤0.01%	2967
2020 Q4	$210K	Buy	+4,241	New	+$190K	﹤0.01%	2795
2019 Q3	–	Sell	-11,051	Closed	-$317K	–	2862
2019 Q2	$317K	Buy	11,051 +65	+0.6%	+$1.81K	﹤0.01%	2469
2019 Q1	$314K	Buy	10,986 +1,469	+15%	+$38.5K	﹤0.01%	2333
2018 Q4	$226K	Sell	9,517 -3,628	-28%	-$99K	﹤0.01%	2398
2018 Q3	$456K	Buy	13,145 +946	+8%	+$31.9K	﹤0.01%	2136
2018 Q2	$400K	Buy	12,199 +619	+5%	+$20.3K	﹤0.01%	2136
2018 Q1	$382K	Buy	+11,580	New	+$378K	﹤0.01%	2119

Other funds holding BBC

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Stifel Financial's BBC Position: Q3 2021 in Review

Stifel Financial sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q3 2021, closing a stake of 4,081 shares — an estimated $204K sold.

Stifel Financial first reported a position in BBC in Q1 2018 and held it in 9 quarters. The position peaked at $456K in Q3 2018. 21 funds tracked by Wall St. Rank hold BBC as of Q3 2021.

Stifel Financial reported no remaining Virtus Biotech Clinical Trials ETF position as of Q3 2021 after selling out during the quarter.
Stifel Financial sold 4,081 Virtus Biotech Clinical Trials ETF shares in Q3 2021, an estimated $204K.
Stifel Financial first reported a position in Virtus Biotech Clinical Trials ETF in Q1 2018 and held it in 9 quarters.
Stifel Financial's Virtus Biotech Clinical Trials ETF position peaked at $456K in Q3 2018.
21 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q3 2021.

Based on Stifel Financial's 13F filing for Q3 2021, filed 15 Nov 2021.